News

Eerste in Afrika

Atriale Fibrillasie, algemeense hartritme-defek met nuwe tegnologie behandel Die eerste geval in Afrika waar ’n pasiënt met revolusionêre nuwe tegnologie behandel is om ‘n hartritme-defek te herstel, is Maandag in die Kaapse Skiereiland gedoen. Die nuwe tegnologie bekend as elektro-porasie is uiters nuut, maar baie opwindend en kan moontlik tot ’n omwenteling in die behandeling van nie net atriale fibrillasie nie, maar alle ander hartritme-defekte lei. Die eerste pasiënt, mnr Robert Reynecke (59) van Proteavallei, het kort na die prosedure, geglimlag. Geen teken van die hartritme-defek is sigbaar nie en kon selfs nie eens met verskeie probeerslae in die teater weer opgewek word nie. Mnr Reynecke se hart-ritme is nou normale sinus-ritme, het Dr Razeen Gopal, hartritme-spesialis van die Cape Town AF Center by die Panorama Mediclinic in die Kaapse Skiereiland, gesê. Die nuwe tegnologie, bekend as pulsveld-ablasie (of elektro-porasie), is baie nuut. Hoewel dit al in Europa, Engeland en die Midde-Ooste beskikbaar is, is dit nou in Suid-Afrika beskikbaar vóórdat dit in Amerika of Kanada beskikbaar is. Volgens Prof Nico Reinsch, hartritme-spesialis van Essen in Duitsland, onder wie se toesig die eerste reeks van dié nuwe behandelings vandeesweek gedoen word, kan elektroporasie beskryf word as revolusionêr en nie bloot evolusionêr nie. In die tagtigerjare het hartspesialiste probeer om hartritme-defekte met direkte elektriese ladings te behandel, maar die ladings was te moeilik beheerbaar, nie akkuraat genoeg nie en het groot skade aan omliggende hart- en ander weefsel veroorsaak. Dit is gestaak. Nou is die lewering van direkte elektriese ladings aan selle dramatiese verfyn tot die nuwe tegniek. Elektro-porasie is anders as enige vorige ablasie-tegnieke, soos hitte (ook bekend as radio-frekwensie) of yskoue (krio-ballon), wat tot dusver gebruik is om atriale fibrillasie te behandel. Met die nuwe tegnologie, wat ook per hartkateter via die femorale aar in die lies tot in die hart geplaas word en dan deur die septum na die linker atrium gestoot word, word vinnige, beheerde elektriese pulse binne mikrosekondes op die regte plekke afgevuur. Die elektriese ladings word deur die toestel aan die voorpunt van die kateter vrygestel. Die toestelletjie ontplooi eers halfpad soos ’n mandjie en dan soos ’n blommetjie met vyf kroonblare. Die spesifieke frekwensie wat ingespan word, skiet mikro-porieë in die selmembrane wat daartoe lei dat die spesifieke selle waarop die ‘skote’ gemik is, sterf terwyl geen omliggende weefsel beskadig word nie. Geen omliggende weefsel word beskadig nie, omdat hartweefsel die gevoeligste is vir die lading en frekwensie van die elektriese skote, terwyl ander weefsel se drempelwaardes vir skade hoër is. As dit nie die geval was nie, was elektroporasie nie moontlik nie, het prof. Reinsch verduidelik. Die voordele van die nuwe tegnologie is dat dit baie vinnig is – die ablasie self duur in ervare en kundige hande skaars ‘n minuut – en dat dit doeltreffend is om atriale fibrillasie toeltreffend te behandel. Voorts is dit veiliger as enige ander tegnologie omdat die frekwensie van die pulse so laag en spesifiek is dat dit slegs die hartselle waarop dit gemik word, laat sterf, maar geen ander weefsel nie, het dr Gopal gesê. Hoewel die nuwe tegnologie nog baie nuut is, het die studies wat sedert 2018 gedoen word, uiters belowende resultate getoon, en lewer die sentra in Europa en Engeland waar die elektroporasie nou ingespan word, dieselfde goeie resultate as in die studies. “Ek is baie hoopvol dat hierdie nuwe tegnologie inderdaad die tegnologie van die toekoms gaan word, en dat alle gevalle van atriale fibrillasie wat met ablasie behandel kan word, binne ’n jaar of twee met elektroporasie behandel sal word.’’ Dr Gopal voorsien dat die nuwe tegnologie in die toekoms ook ingespan sal word om alle ander hartritme-defekte soos Wolf-Parkinson-White sindroom in kinders te behandel, want navorsing is reeds aan die gang om die toestelletjie waardeur die elektriese stroom die hartweefsel raak, te verander in ’n fokus-toestelletjie wat foutiewe weefsel puntsgewys kan vernietig.

News

Watch our recent Masterclass Sessions in Cardiology

Sessions by renowned international cardiology experts 2. Renal denervation in dthe managent of resistant hypertension: Dr Riaz Dawood, Lenmed Clinic. 3. Complex percutaneous coronary intervention (PCI) for high bleeding risk patients: Prof Ivo Petrov, Univerity of Sofia, Bulgaria. 4. TAVI/Percutaneous valves – An update for 2021: Dr Adriaan Horak, cardiologist, Vincent Pallotti Hospital 5. Ablation for Artrial Fibrillation (AF) – The critical importance of early intervention: Prof Richard Schilling, St Bartholomews, London, UK. 6. An update on the European Heart Rhythm Association (EHRA) – Practical novel oral anti-coagulants (NOAC) use guide: Prof Jan Steffel, University Hospital Zurich, Switzerland 7. Judicious use of antiarrhythmic drugs and ablation in the management of AF and heart failure: Prof Timothy Betts, Oxford University Hospital, NHS Foundation Trust, UK 8. Stroke and Atrial Fibrillation (AF) – make the LINQ: Prof Helmut Purerfellner, Ordensklinikum Linz, Austria 9. Applied anatomy for the interventional cardiologist and electrophysiologist: Prof Maxim Didenko, Kirov Military Medical Academy, Russia. 10. Conduction system pacing – State of the art – the future is here: Dr Pugazhendhi Vijayaraman, Geisinger Heart Institute, USA 11. Device therapy and automic modulation in heart failure: Prof Michael R Gold, Medical University of South Carolina, USA. 12. An appraisal of the 2021 heart failure and pacing guidelines: Dr Muzahir Tayebjee, Leeds Teaching Hospital, NHS Trust, UK. 13. Ethics: Doctors in the resource constraint environment: Elsabé Klinck, South Africa 14. Wrap Up: Dr Razeen Gopal

News

Treatment with most advanced therapy for management of atrial fibrillation will change a teenager’s life today

Today an 18-year-old boy with atrial fibrillation (AF) has become the first patient in Africa and the Middle East to be treated with the latest and most advanced therapy available in the management of atrial fibrillation. According to Dr Razeen Gopal, renowned cardiologist and electrophysiologist at the Cape Town AF Centre (CTAFC) based at Mediclinic Panorama, ablation therapy is the most effective manner to treat atrial fibrillation especially of recent onset or of short duration. AF is described as a ‘chaotic heart rhythm’ and remains a common cause of stroke. Cryo-ablation is at least as effective, if not superior to thermal energy (radio- frequency) ablation. Current literature has consistently confirmed that balloon-based procedures for atrial fibrillation such as cryo-ablation, are considerably safer than radio-frequency based ablation procedures, with a markedly reduced chance of cardiac perforation.” I would imagine this latest cryo-balloon technology now offers us an even safer option” Dr. Gopal explained. Christopher Groenewald was diagnosed with symptomatic longstanding persistent atrial fibrillation, with severely compromised quality of life. His AF has proved to be most debilitating, causing recurrent palpitations, dizziness and fatigue. He was accepted for Dr. Gopal’s cryo-ablation programme once an implantable loop recorder (a small recording device, the size of a matchstick injected just below skin), confirmed the absence of simpler cardiac rhythms, serving as catalysts or triggers for his AF. “All our team wants to do is change lives by giving patients back the type of lifestyle quality they were previously able to enjoy,” Dr Gopal said. “I feel quite privileged that our centre has been chosen to showcase this latest innovation confirming our status as one of the leading centres in the region (Middle East and Africa” Dr Gopal said. The technology used was the POLARx  device introduced by industry leader Boston Scientific. [Watch Animation of POLARx cryo-ablation here: https://www.youtube.com/watch?v=ala9cVG0yFI&feature=youtu.be] With the latest technology, an experienced electrophysiologist can change the life of a person with a minimally invasive procedure generally lasting under an hour. The new POLARx cryo-ablation system has been designed and built from the ground up to retain the best of an established approach and performance of cryo-ablation with additional expert-driven changes for an improved experience in the ablation procedure. The introduction of the re-engineered therapy will be incorporated into treatment options going forward so as to give comprehensive and patient-centric options for the best treatment outcomes. Further notes Notes on Atrial Fibrillation Atrial Fibrillation (or AF) is the most common heart rhythm disorder and affects one in eight people over the age of 60 years, but increasingly also affects younger people. Its incidence usually increases with age. AF is an irregular heart rhythm that affects the upper chambers (atriae) of the heart. Due to extra electrical signals entering particularly the left upper chamber, the atriae may contract at a fast or slow rate but with an always irregular and chaotic rhythm. This quivering form of contractile dysfunction, instead of normal synchronous beating, may result in the turbulent flow of blood in these upper chambers, leading to pooling and clotting due to the slow flow, and resulting in catastrophic stroke. Treating AF is important because:  Untreated AF leads to an elevated (up to 5 – 10 times higher) risk of stroke, since a blood clot from the atriae may lodge in the brain. This risk is elevated particularly in people with a history of stroke, diabetes, hypertension or those older than 65 years; If the irregular heart rhythm continues on a permanent basis in a rapid and uncontrolled fashion (known as persistent AF) it can lead to heart failure, since the pumping chambers (ventricles) cannot contract effectively at a sustained rapid rate. Untreated AF may eventually lead to changes in the heart’s electrical architecture, resulting in worsening of irregular heart rhythms. AF is associated with symptoms of fatigue, shortness of breath, listlessness, palpitations, chest discomfort, dizziness and fainting, and deleteriously affects quality of life. More about cryo-ablation How it works Cryo-ablation makes use of extremely low temperature (intense cold energy) to eliminate the effect of malfunctioning cells that spark additional electrical signals. The heart’s rhythm and rate can therefore not be regulated. Two catheters are inserted through the groin and into the femoral veins, which are then pushed up into the right atrium of the heart. They are positioned in the left atrium through a small hole made in the septum, a membrane separating the two chambers. A cryo-balloon is inserted at the base of one of the four pulmonary veins, inflated and cooled. This creates a contiguous ring of strategically damaged heart tissue, which effectively blocks faulty signals. The process is then repeated on the other three pulmonary veins entering the left atrium. Cryo-ablation has revolutionised the early treatment of atrial fibrillation and is now used universally in the management of both paroxysmal and persistent AF. The Consensus Statement of the European Cardiac Society state in their guidelines that cryo-ablation may be used as first line therapy for the management of symptomatic, intermittent (in particularly new onset) as well as persistent (longstanding) atrial fibrillation. High success rate; Less complications The technology has the added advantage of hardly, if ever, causing additional rhythm disturbances as a consequence of lesion formation, as in the case of radio-frequency ablation. Dr Gopal notes that this has been a major step forward as these post-ablation arrhythmias related to scarring, from heat energy, may be the bane of existence of any electrophysiologist, often being very difficult to localize and cure. In the interim newer generations of anti-clotting medications also have emerged in the battle against stroke. Currently, studies have shown, that early ablation treatment leads to better long-term results and improved quality of life. Dr. Gopal emphasises that the earlier patients are referred in the course of their disease the better the outcome of the therapy. In the hands of an experienced and competent electrophysiologist the risk for complications is extremely low for either cryo-ablation or radio-frequency ablation Approximately 90% of patients with paroxysmal (intermittent) AF stop taking

News

Why conduction system pacing is the most synchronized physiological pacing modality of the future?

In a nutshell: Patients with a bradycardia (slow heart rate) or conduction system disease, can now be paced more effectively with a procedure referred to as His Bundle Pacing (HBP). The conduction system is stimulated directly, allowing both ventricles to contract simultaneously. This leads to better patient outcomes, and bypasses the risk of developing left bundle block, often the result of long-term traditional pacing. HBP is hailed as the ‘pacing of the future’. The procedure can generally only be performed by an electrophysiologist. It requires a steep learning curve and often success rates may vary depending on patient anatomy and substrate. The technique is a very suitable alternative or adjunct to CRT (cardiac resynchronize therapy). However, the results of randomized controlled studies are pending. Quick notes His‐Purkinje conduction system pacing (HPCSP) in the form of His bundle pacing (HBP) and left bundle branch pacing (LBBP) allows normal left ventricular activation, thereby preventing the adverse consequences of right ventricular pacing. HBP has been established for several years with centers from China, Europe, and North America reporting their experience. There is international guidance as to how to implant such systems with the differing patterns of His bundle capture clearly described. LBBP is a more recent innovation with potential advantages including improved pacing parameters. HPCSP has been extensively studied in a variety of indications including cardiac resynchronization therapy, atrioventricular node ablation, and bradycardia pacing. His bundle (HB) pacing is an established modality for achieving physiological pacing with a low risk of long‐term lead‐related complications. The development of specially designed lead and delivery tools has improved the feasibility and safety of HB pacing (HBP). Knowledge of the anatomy of HB region and the variations is essential for successful implantation. Newer delivery systems have further improved procedural outcomes. Challenging implant cases can be successfully performed by reshaping the current sheaths, using “sheath in sheath” technique or “two‐lead implantation technique.” Special attention to the lead parameters at implant, programming, and follow‐up is necessary for successful long‐term outcomes with HBP. Widespread use of HBP by electrophysiologists and further advances in dedicated delivery systems and leads are essential to further improve the effectiveness of the implantation. HIS Bundle Pacing Summary Slides    

News

Skrik wakker; slaap-apnee beskadig jou hart

Wat het slaap-apnee en snork met jou hart te doen? Baie meer as wat jy ooit kon droom. As jy of jou maat aan snags ophou asemhaal en dan weer skielik na asem snak, MOET jy eenvoudig na dié program luister. Onbehandelde slaap-apnee met hartprobleme kan jou lewe met 20 jaar verkort. Sowat 1 uit 15 mense lei aan obstruktiewe slaap-apnee. Sowat 50% van mense met slaap-apnee is ogediagnoseerd. Tussen 15% en 50% van mense met Atriale Fibrillasie (‘n hartritme-defek wat tot beroerte kan lei) het slaap-apnee. Daar is meer as een vorm van slaap-apnee naamlik sentrale slaap-apnee tydens hartversaking en obstruktiewe slaap-apnee. Slaap-apnee speel net so groot rol in hartprobleme, skielike hartstilstand en hartversaking/beroerte as onbeheerde glukosevlakke van ongekontrolleeerde diabete en verhoogde LDL-cholesterolvlakke. Marí Hudson gesels met Dr Razeen Gopal, ’n hartspesialis wat gespesialiseer het in hartritme-defekte. Hy vertel meer oor die jongste feite oor slaap-apnee en hartprobleme en hoe die vurk in die hef steek. Die bevindings van die jongste navorsing kan jou dalk slapelose nagte besorg. Gesondheid Volledige Lys Die meganisme hoe slaap-apnee jou hart beskadig Die kaskade van gebeure wat volg as jy aan slaap-apnee ly (en later ‘n lewe van sy eie kry), is as volg: Stap 1: As jy snags in jou slaap vir sowat 10 sekondes ophou asemhaal, en dan weer met ‘n snak of groot asemteug begin asemhaal, beteken dit dat die suurstofvlakke in jou bloed daal (bekend as hipoksie) en die koolstofdioksiedvlakke in jou bloed styg (bekend as hiperkarbie) In sommige gevalle kan jou suurstofvlakke so laag daal dat dit slegs 10% van jou normale suurstofvlakke is. Stap 1 lei tot Stap 2: Die lae suurstofvlakke en hoë koolstofdioksied-vlakke in jou bloed veroorsaak ‘n staat van skadelike oksidatiewe stress en inflammasie in jou liggaamselle. Hierdie oksidatiewe stress en inflammasie in ook die endoteel (voeringlagie) van die koronêre vate wat die hart van bloed voorsien, asook die binnevoeringlagie van die hart, veroorsaak skade aan die binnekant van dié bloedvate en die hart. Stap 2 lei tot groter risiko vir hartaanvalle Stap 1 lei ook tot Stap 3: Terselfdertyd veroorsaak die lae suurstofvlakke en hoë koolstofdioksiedvlakke dat die ribbekas se spiere wat jou help om asem te haal, abnormaal begin beweeg. Stap 3 lei tot Stap 4: Die abnormale asemhalingsbewegings lei tot verhoogde druk binne-in die borskas. Dit staan bekend as verhoogde intra-torakale druk. Stap 4 lei tot stap 5: Verhoogde druk binne-in die borskas lei tot aktivering van die simpatiese senuweesisteem – dit is jou veg-en-vlug reaksie en gaan gepaard met verhoogde noradrenalien (in die brein) en verhoogde adrenalien (wat deur die byniere afgeskei word), want jou liggaam besef jy is in die nood. Stap 5 lei tot Stap 6: Die oor-aktivering van jou veg-en-vlug reaksie lei tot skielike stygings in jou bloeddruk en in jou polsspoed (veral in die stadium wat jy ná asem-ophoud weer begin asemhaal) ventrikulêre hartritme-stoornisse, veral tussen 6 vm en 12 vm. Dit gebeur Stap 6 lei tot stap 7: Die verhoogde bloeddruk en binne-borskasdruk lei daartoe dat die hart se regterventrikel harder moet pomp om die bloed in die longe te kry. Dit kan lei to regterhartversaking. Stap 7 lei tot stap 8: Meer bloed keer terug na die linker-atria (linker vulkamer). Stap 8 lei na stap 9: Meer bloed in die linker vulkamer veroorsaak wat dat nog meer bloed na die linker pompkamer vloei. Die linker pompkamer kan ook rek en vergroot en hulle wande verdik. Stap 2 en 9 lei tot ook tot stap 10: Die rekking van die pompkamers beskadig die geleidingsweefsel en veroorsaak ook littekenweefsel in die pompkamers. Dis ‘n giftige kombinasie vir die hart. Stap 8 en 9 lei tot stap 11: Die bloedvloei in die vulkamers vloei nou nie meer in ‘n netjiese stroom nie, maar begin te warrel, weens veral skade aan die geleidingsweefsel in die linker-atrium. Die skade lei ook tot onreelmatige en ongesinchroneerde hartklop, bekend as Atriale Fibrillasie. Tydens AF veroorsaak dié turbulente vloei veroorsaak dat die bloed stadiger aan die buitekant van die turbulensie vloei, en dan begin stolsels vorm. Atriale Fibrillasie is die algemeenste hartritme-defek onder mense ouer as 60 jaar, en een van die oorsake van beroerte. Stap 11 lei tot stap 12: Die stolsels kan deur die liggaam gepomp word en in die brein beland (beroerte) of in ledemate of in jou oog. Stap 12 lei tot stap 13: ‘n Beroerte kan noodlottig wees. Stap 9 lei ook tot stap 14: Die risiko vir Skielike hartstilstand, ‘n hartaanval, hartversaking en dood is beslis verhoog. Diagnose van slaap-apnee ‘n Slaapstudie is nodig waar verskeie dinge soos bloeddruk, suurstofvlakke en veel meer gemeet word. Die asemophoud moet ook minstens 10 sekondes duur. Die behandeling As die begenoemde kaskade van gebeure eers aangeskakel is, is dit moeilik om af te skakel en om te keer. Maar dit kan omgekeer word as al die aspekte van die kaskade behandel word. As die slaap-apnee die gevolg is van ‘n anatomiese obstruksie in die neus of keel, moet dit reggestel word. ‘n C-Pap masker is nodig om te verseker dat jou suurstofvlakke nooit te laag daal nie. Jou AF kan behandel word deur ‘n Krioballon-ablasie Gewigsverlies en gereelde oefening is ook kardinaal. Wie het ‘n verhoogde risiko vir Slaap-apnee en hartprobleme en skielike dood? Mense met hoë bloeddruk en/of diabetes Mense met bestaande hartprobleme Oorgewig mense Mense wat min oefening doen Mense met ‘n dik nek en ‘n groot nek-omtrek. Snork/maklik verstik Slaap maklik in dag weens moegheid  

News

Ventricular arrhythmias: New solutions for deadly heart conditions

The first emerging market regions implantation of the world’s smallest smart device to control heart beats and pumping action was performed yesterday by Dr Gopal and his team at the Cape Town AF Centre, Panorama hospital, Cape Town.  These devices, known as Implantable cardioverter-defibrillators (ICD), are increasingly being used worldwide and also in developing countries, predominately for the management of life-threatening cardiac rhythm disorders. The Cape Town AF Centre with its experience of using these devices and its leading role in teaching doctors about electrophysiology, implanted this device in a 77yr old patient with ischaemic cardiomyopathy (poor cardiac function due to coronary artery disease). He has had a successful ablation of his ventricular tachycardia with Dr. Gopal. The new device, produced by Biotronik, has only recently been introduced in Europe, so this South African application has occurred very early in the introduction of this medical device worldwide. Unique features of this heart-support device are its greater longevity, reliability and ease of implantation; these are very important attributes in developing environments. The battery of the ICD device lasts for up to 15 years. The more sophisticated device which offers synchronisation of heart chamber pump action plus a ‘shock/defibrillation’ function has a battery which lasts for up to 9 years. This ultra slim and bio shaped device (10mm) is smart and can provide information directly to the clinic or doctor’s surgery remotely. It can also be kept working while full or partial body scans are done for diagnosis of other diseases. Dr. Gopal’s unit remains one of the leading centres for management of cardiac arrhythmias on the African continent and he feels that the addition of the new platform of devices is in keeping the centre’s motto that “with innovation, comes cure”.  

CTAFC: 600 Cryoballoon cases and counting

28 January 2019 DR GOPAL PERFORMS 600th CRYO-ABLATION PROCEDURE Dr Razeen Gopal, renowned cardiologist and electrophysiologist based at Mediclinic Panorama, performed his 600th cryo-ablation procedure on Monday, 21 January 2019. According to Medtronic South Africa, this is the first time a single operator has completed 600 cryo cases within the MEACAT (Middle East Africa and Turkey) region. In 2011 Dr Gopal was one of the first South African specialists to start performing these procedures in high volumes. The 600th patient, Mr Paul Dinsmore, aged 61, from Newlands is a telecoms consultant and avid endurance trainer, and was referred to Dr Gopal for the ablation procedure. He underwent the surgery on Monday and hopes to return to endurance training in the near future. Cryo-ablation makes use of extremely low temperature (intense cold energy) to eliminate the effect of malfunctioning cells that spark additional electrical signals. The heart’s rhythm and rate can therefore be regulated. Two catheters are inserted through the groin and into the femoral veins, which are then pushed up into the right atrium of the heart. They are positioned in the left atrium through two small holes made in the septum between the two chambers. A cryo-balloon is inserted at the base of one of the four pulmonary veins, inflated and cooled. This cooling from the balloon creates a contiguous ring of strategically damaged heart tissue, which effectively blocks faulty signals. The process is then repeated on the other three veins.  

Wanneer is ‘n vinnige hartklop gevaarlik?

Waarom klop ’n mens se hart soms te vinnig, te stadig of onreëlmatig? Wanneer is dit gevaarlik? Kan of moet dit behandel word? Hoe word dit behandel? Luister hier na die onderhoud wat Marí Hudson op RSG gevoer het oor hartritme-defekte wat in die pompkamers ontstaan met Dr Razeen Gopal, hartritme-spesialis van die Kaapstad Sentrum. Laai Af (26 223KB) Teken in met iTunes Luister

Nuwe, gevorderde Hisbondel-pasaangeërs laat selfs swak harte sterker klop

Nuwe, gevorderde pasgeër-inplantingsprosedure wat selfs verswakte hart sterker laat klop, is nou in Kaapstad beskikbaar ‘n Té stadige hartklop, is algemeen in ouer mense en is gewoonlik die gevolg van ‘n blokkasie in die hart se spesiale elektriese geleidingsweefsel, soms ná ‘n hartaanval. Nou het medici ‘n manier gevind om die geleidingsweefsel van die hart vir die eerste keer regstreeks te stimuleer sodat die twee pompkamers weer presies soos ‘n normale hart saamtrek: sterk en sinchronies. Die nuwe, gevorderde pasaangeër-prosedure staan bekend as His-bondel-pasaandrywing. Die inplanting van die eerste reeks leermeester-gedrewe His-bondeltak-pasaangeërs is op 2 en 3 Mei by die Kaapstad AF sentrum in Mediclinic Panorama gedoen. ”Ek beskou His-bondeltak-pasaandrywing as die pasaangeër-prosedure van die toekoms beskryf omdat dit die eerste metode is waar die hart se eie geleidingsweefsel regstreeks gestimuleer word en só die hart se twee pompkamers weer gesinchroniseerd en sterk laat saamtrek,”  het dr. Razeen Gopal, kardiale elektrofisioloog van die Kaapstad AF Sentrum, wat die reeks gelei het, gesê. “Ons sal dit in die toekoms beskryf as die ‘herstel van sinchroniese sametrekking’  wat ‘n stap verder is as bloot pasaandrywing,” sê dr. Gopal. Reeds tydens die inplantingsprosedure, wat gemiddeld skaars 20 minute duur, kan duidelik gesien word hoe selfs ‘n verswakte hart se EKG-golwe weer fisiologies normaal word omdat die twee pompkamers weer sterk en sinchronies saamtrek, wat nie voorheen met tradisionele pasaangeërs vermag kon word nie. Al ses pasiënte wat in die eerste reeks met dié nuwe en gevorderde metode pasaangeërs ontvang het waar die elektrodes op ‘n nuwe manier ingeplant is, se prosedures was suksesvol. Almal voel meer energiek en se kwaliteit van lewe het verbeter, juis omdat sinchroniese sametrekking van die twee pompkamers herstel is, het dr. Gopal bevestig. Die Kaapstad AF Sentrum is slegs die tweede sentrum in die land waar His-bondel-pasaandrywing gedoen is, en die eerste waar die eerste reeks onder leermeester-toesig gedoen is. Dr Israel Obel van Netcare Milpark Hospital in Johannesburg het in Julie verlede jaar die eerste His-bondel-pasaangeër in Suid-Afrika in ‘n pasiënt ingeplant en sedertdien nog sowat vyf gevalle gedoen. Dr. Gopal is gereed om binnekort die tweede reeks pasiënte te behandel. Hoe werk normale hart-geleiding en die prosedure? Die prosedure word His-bondel-pasaandrywing genoem omdat die hoof-elektrode van die pasaangeër nie bloot in die regter-pompkamer geplaas word nie, maar met ‘n spesiale skroefpunt teen die His-bondeltak, die hart se eie geleidingsweefsel wat die boonste deel van die hart elektries met die onderste deel van die hart verbind. Die prosedure is ingewikkelder as die inplasing van die elektrodes van tradisionele pasaangeërs. Die His-bondeltak verloop van bo na onder in die septum tussen die linker- en regterhartkamers, en vertak in twee of drie bondeltakke wat na en om die pompkamers verloop. Dié bondeltakke bestaan uit spesiale geleidingselle wat die elektriese seine soos blits gelei sodat die elektriese stroom bykans oombliklik en gelyktydig albei pompkamers bereik en dus gelyktydig prikkel om gelyktydig saam te trek. Die gelyktydige, gesinchroniseerde sametrekking deur beide pompkamers is noodsaaklik om maksimum uitwerping van die bloed uit die twee pompkamers te verkry. Met ‘n gewone pasaangeër, waar die elektrode in die regter-pompkamer geplaas word, word die impulse vanaf die elektrode nie deur die elektriese ‘snelweg’ gelei nie, maar stadiger deur die gewone hartspierselle. Omdat die pad na die linker-pompkamer langer is as na die regter-pompkamer, bereik die impulse die linkerkant later, en trek die linker-pompkamer eers ‘n sekonde of meer ná die regterkant saam. Op die lang duur, kan ongesinchroniseerde sametrekking van die twee pompkamers stremming op die hart plaas, en begin die EKG-golwe lyk soos linkerbondel-blok. Elke millisekonde verskil in die sametrekkings-aanvang tussen die twee pompkamers, kan weliswaar ‘n verskil maak aan hoe sterk die hart as geheel klop. Die toekoms ”His-bondel-pasaandrywing is die eerste fisiologies-korrekte pasaandrywing”, het Dr. Zachary Whinnett, kardiale elektrofisioloog verbonde aan die Nasionale Hart- en Longinstituut by die Geneeskunde fakulteit van die Imperial College NHS Trust en die Hammersmith en St Mary’s Hospitale in London verduidelik. Hy was in Suid-Afrika as ‘proctor’ oftewel spesialis-leermeester om dr. Gopal by te staan in dié reeks wat in Kaapstad gedoen is. Die inplanting van His-bondeltak-pasaangeërs is nog in sy kinderskoene en die data van dubbel-blinde kliniese studies is nog nie beskikbaar nie, maar Dr. Whinnett beskou dit as die soort pasaangewing van die toekoms veral vir pasiënte met ‘n stadige hartklop weens hartblok of bondeltakblok van enige van die His-bondeltakke, en met boon-op verswakte hartfunksie, juis omdat die hart se pompkamers ná His-bondeltak-pasaangewing weer sinchronies en dus sterkter saamtrek. Luister hier hoe dr. Gopal self verduidelik hoe en waarom His-bondel-pasaandrywing gedoen word en watter pasiënte gehelp kan word: Laai Af (25 181KB) Teken in met iTunes Luister           New treatment option made available to patients with irregular heartbeat  Advanced cardiac pacemaker procedure performed for first time under proctor supervision in SA The ‘His-bundle’ is electrically connecting the upper and lower chambers of the heart. A heart rhythm disorder or cardiac arrhythmia is when the heart beats too quickly, too slowly or irregularly. This is caused by a fault or faults in the electrical circuitry of the heart. Electrophysiology is the study of the electrical properties of the heart’s cells and tissues and aims to diagnose and successfully treat cardiac arrhythmia. While many South Africans are unaware of the medical condition, an irregular heart beat or arrhythmia is actually quite common, and in some cases can be extremely serious, causing a sudden, cardiac event such as heart failure.

Geslaagde humanitêre missie na Dakar, Senegal

6 April 2018. – Dr Razeen Gopal het pas teruggekeer van ‘n geslaagde humanitêre missie na Dakar Senegal, waar hy binne vier dae ablasie-prosedures op 18 pasiënte met lewensgevaarlike hartritme-defekte, uitgevoer het. Dr. Gopal het op versoek van prof. Adama Kane, kardioloog van die Institiuut vir Kardiologiese Intervensies in Dakar  gaan help om dié pasiënte te help. Al die pasiënte was jonger as 30 jaar. Prof. Kane werk in ‘n hospitaal wat soos in ‘n ouerige huis lyk, in ‘n teater met toerusting wat ouer as 10 jaar is. Prof. Adama het opleiding in Frankryk ontvang en ook opleiding in prosedures om basiese hartritme-defekte te behandel, in Kaapstad onder dr. Gopal ondergaan het. Deel van die doel van die missie, was om Prof. Adama te help om self van die hartritme-defekte te kan herstel. Dr. Gopal is vergesel deur Ryan Leon, kliniese tegnoloog in kardiologie/elektrofisiologie. Die twee het die eerste dag ná hul aankoms bestee om die beskikbare toerusting te herstel en so veilig moontlik te maak vir die pasiënte. Daarna het hulle 18 pasiënte met lewensbedreigende Wolff-Parkinson-White hartritme-defek, gehelp, deur die bron van die addisionele elektriese stroombaan in die hart, te inaktiveer deur radiofrekwensie (termiese of hitte-) ablasie. Twee van die pasiënte se addisionele elektriese stroombane was op té gevaarlike plekke in die hart gelëe om met die ou toerusting te behandel, en sal nou op Dr. Gopal se versoek na Kaapstad kom sodat hy die prosedures hier kan doen. Hier is ‘n video van die gebeure wat deur die Franssprekende televisiekanaal in Dakar gemaak is: WOLFF-PARKSINSON-WHITE is ‘n arritmie wat veroorsaak word deur ‘n abnormale brug van elektriese weefsel wat die artria en ventrikels verbind. Hierdie ekstra elektriese stroombaan laat toe dat elektriese seine heen en weer tussen die boonste en onderste hartkamer kan hardloop sonder dat dit deur die AV-node gelei word. Die gevolg is ‘n baie vinnige hartklop wat lewensgevaarlik kan wees. (Lees meer hartritme-defekte in die boekie inEngels  en in Afrikaans. Die missie is verder moontlik gemaak deur verskaffers van toerusting, soos Medtronic, Boston Scientific en andere, wat die prosedures moontlik gemaak het.

Opsionele Kantlys 1

Opsionele Kantlys 2

Kantlys 2